Home » Topics » BioWorld Science

BioWorld Science
RSS

Asahi Kasei presents preliminary results of SCARLET phase III trial of ART-123

Aug. 3, 2018

Researchers develop new rat model of tauopathy with severe cognitive deficits

Aug. 3, 2018

Emergent BioSolutions starts phase I study of ZIKV-IG

Aug. 3, 2018

SciBac's development of SCB-102 for C. difficile infection supported by CARB-X award

Aug. 3, 2018

ApoE has role in birth of neurons in adult brain

Aug. 3, 2018

Bioelectron Technology identifies new resorufin derivatives

Aug. 2, 2018

EC expands approval of Jinarc to include ADPKD patients with stage 4 CKD

Aug. 2, 2018

Medshine Discovery presents thiazole derivatives for HSV infections

Aug. 2, 2018

Samumed presents characterization and preclinical results for SM-07883

Aug. 2, 2018

Theravance Biopharma reports 4-week results from phase II study of TD-9855 in nOH

Aug. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...